About iberdomide hydrochloride
Cereblon E3 ligase modulator
Used for
- Investigational treatment for multiple myeloma; not an established approved treatment.
Usual adult dose
No approved standard dose; dosing is determined in clinical trials.
Common side effects
- Low blood cell counts
- Infections
- Fatigue
- Nausea
Important warnings
- Investigational medicine; use only under clinical-trial supervision.
- May cause serious birth defects; pregnancy prevention and testing are required in trials.
- Can suppress blood cell production and increase infection risk.
- Follow trial requirements for blood tests and contraception.
Pregnancy
Avoid during pregnancy; may cause serious harm to an unborn baby.
Breastfeeding
Breastfeeding is not recommended during treatment; safety is unknown.
Interactions
- Medicines affecting CYP3A enzymes may alter iberdomide exposure.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.